ARCHIVES

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

This article is from The Cancer Letter archive.

Vol. 19 No. 11 | March 12, 1993

Download PDF Visit The Full Archive

Related Articles

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

April 27, 2001

In Brief: Mauer New AACI President, Steckel Named President-Elect; Prevention Conference Set

January 25, 1980

Other NCI funding opportunities listed.

July 9, 2004

Wilmot Researchers Study Combination for Lymphoma

September 26, 2003

RFP: Sole Source

May 12, 2000

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999